Presently, Miguel Forte occupies the position of Chief Executive Officer & Director at Bone Therapeutics SA. Dr. Forte is also on the board of Alliance for Regenerative Medicine and Associate Professor at the University of Lisbon and Associate Professor at the University of Aveiro.

Dr. Forte previously occupied the position of Chief Executive Officer for Zelluna Immunotherapy AS, Medical Director for Bristol Myers Squibb Co., Chief Medical Officer of Bone Therapeutics SA, VP-Clinical, Medical & Regulatory Affairs at Nabi Pharmaceuticals, Chief Commercialization Officer at International Society for Cellular Therapy, Chief Operating Officer & Senior Vice President for Sangamo Therapeutics France SAS and Vice President-Medical Affairs at Union de Crédit Pour le Bâtiment SA.

Miguel Forte received an undergraduate degree from the University of Lisbon and a doctorate from the University of Birmingham.